Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer

ANZ Journal of Surgery

Volumn 81, Issue 10, 2011, Pages 688-693

  Kiely, Belinda E ^a   Hossack, Lucinda K ^a   Shadbolt, Clair L ^a   Davis, Anna ^a   Cassumbhoy, Robin ^a   Moodie, Kate ^a   Antill, Yoland ^a   Mitchell, Gillian ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

BRCA1 and BRCA2; Breast cancer screening; Hereditary breast cancer; High risk; Magnetic resonance imaging

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; AUSTRALIA; BREAST TUMOR; COMPARATIVE STUDY; EVALUATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SATISFACTION; QUESTIONNAIRE; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MIDDLE AGED; MUTATION; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VICTORIA; YOUNG ADULT;

EID: 80053439347     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05581.x     Document Type: Article

References (25)

1. Ford D, Easton DF, Stratton M etal. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1998; 62: 676-89.
2. Antoniou A, Pharoah PD, Narod S etal. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. [erratum appears in Am J Hum Genet. 2003 Sep;73(3):709]. Am. J. Hum. Genet. 2003; 72: 1117-30.
3. Antill Y, Reynolds J, Young MA etal. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Eur. J. Cancer 2006; 42: 621-8.
4. Brekelmans CT, Seynaeve C, Bartels CC etal. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. [see comment].J. Clin. Oncol. 2001; 19: 924-30.
5. Scheuer L, Kauff N, Robson M etal. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. [see comment].J. Clin. Oncol. 2002; 20: 1260-8.
6. Vasen HF, Tesfay E, Boonstra H etal. Early detection of breast and ovarian cancer in families with BRCA mutations. Eur. J. Cancer 2005; 41: 549-54.
7. Tilanus-Linthorst M, Verhoog L, Obdeijn IM etal. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. [erratum appears in Int J Cancer 2002 Dec 20;102(6):665].Int. J. Cancer 2002; 102: 91-5.
8. Kuhl CK, Schrading S, Leutner CC etal. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J. Clin. Oncol. 2005; 23: 8469-76.
9. Leach MO, Boggis CR, Dixon AK etal. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). [see comment][erratum appears in Lancet. 2005 May 28-Jun 3;365(9474):1848].Lancet 2005; 365: 1769-78.
10. Warner E, Plewes DB, Hill KA etal. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. see comment].JAMA 2004; 292: 1317-25.
11. Kriege M, Brekelmans CT, Boetes C etal. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. [see comment].N. Engl. J. Med. 2004; 351: 427-37.
12. Lehman CD, Isaacs C, Schnall MD etal. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244: 381-8.
13. Sardanelli F, Podo F, D'Agnolo G etal. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007; 242: 698-715.
14. Warner E, Plewes DB, Shumak RS etal. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. [see comment].J. Clin. Oncol. 2001; 19: 3524-31.
15. Trecate G, Vergnaghi D, Manoukian S etal. MRI in the early detection of breast cancer in women with high genetic risk. Tumori 2006; 92: 517-23.
16. Lehman CD, Blume JD, Weatherall P etal. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103: 1898-905.
17. Hagen AI, Kvistad KA, Maehle L etal. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 2007; 16: 367-74.
18. Warner E, Messersmith H, Causer P etal. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann. Intern. Med. 2008; 148: 671-9.
19. Weaver DL, Rosenberg RD, Barlow WE etal. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006; 106: 732-42.
20. Australian Government Department of Health and Aging. Medicare Benefits Schedule online. Commonwealth of Australia [Cited 27 Jun 2009.] Available from URL:.
21. Delille JP, Slanetz PJ, Yeh ED etal. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J. 2005; 11: 236-41.
22. R - magnetic resonance imaging. In: ACR Breast Imaging Reporting and Data System. Reston VA: Breast Imaging Atlas, 2003; 111-13.
23. Kriege M, Brekelmans CT, Boetes C etal. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 2006; 106: 2318-26.
24. Peters G, Anderson J, Longman G etal. Magnetic resonance findings in women at high risk for developing breast cancer: an Australian feasibility study. J. Med. Imaging Radiat. Oncol. 2008; 52: 29-35.
25. National Breast and Ovarian Cancer Centre (NBOCC). Clinical Practice Guidelines. Advice about familial aspects of breast and ovarian cancer. A guide for health professionals. Sydney. [Cited 27 Jun 2009.] Available from URL:.